Drug class
Vitamin K antagonist anticoagulant (4-hydroxycoumarin derivative)
Mechanism of action
Inhibits vitamin K epoxide reductase, reducing regeneration of active vitamin K and gamma-carboxylation of vitamin K-dependent coagulation factors II, VII, IX and X and proteins C and S.
General use cases
- Treatment of thromboembolic diseases
- Prevention of thromboembolic diseases
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
